FBIO · Fortress Biotech, Inc. · Debt

$1.93 +0.06 (+3.21%) At close · Oct 27 Q3 2025 earnings call transcript

Market Cap

$68.78M

36.78M

Volume · Oct 27 157.14K Avg daily vol (3M) 418.62K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Long-term debt, including current maturities	2026-06-30	USD 35,000,000	10-Q filed 2026-08-13
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current portion of notes payable USD 5,000,000 Noncurrent notes payable USD 34,602,000 Notes payable, including current maturities USD 39,602,000
Operating lease liabilities	2026-06-30	USD 13,714,000	10-Q filed 2026-08-13
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current operating lease liabilities USD 2,246,000 Noncurrent operating lease liabilities USD 11,468,000

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1429260 CUSIP 34960Q307 13F (30d) 3 filings 3 filers Visit website Investor relations